z-logo
Premium
Preterm parturition and pre‐eclampsia: The confluence of two great gestational syndromes
Author(s) -
Jayaram Aswathi,
Collier Charlene H.,
Martin James N.
Publication year - 2020
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1002/ijgo.13173
Subject(s) - medicine , eclampsia , obstetrics , pregnancy , aspirin , preeclampsia , preterm delivery , gestational hypertension , gestation , gestational age , pediatrics , genetics , biology
Abstract Background Preterm birth ( PTB ) and pre‐eclampsia independently, and frequently concurrently, adversely affect the pregnancy outcomes of millions of mothers and infants worldwide each year. Objectives To fill the gap between PTB and pre‐eclampsia, which continue to constitute the two most important current global challenges to maternal and perinatal health. Methods Pubmed, Embase, and Cochrane databases were searched from inception until December 2019 using the terms spontaneous PTB ( SPTB ), indicated preterm delivery ( IPTD ), early‐onset pre‐eclampsia, and pre‐eclampsia. Results History of PTB and pre‐eclampsia were the strongest risk factors contributing to the occurrence of SPTB or IPTB . The risk of PTB and pre‐eclampsia among non‐Hispanic African American women was higher than the rate among all other racial/ethnic groups in the United States. Low‐dose aspirin ( LDA ) has been reported to reduce the risk of pre‐eclampsia by at least 10% and PTB by at least 14%. Lastly, women and their fetuses who develop early‐onset pre‐eclampsia are at higher risk for developing hypertension and cardiovascular disease later in life. Conclusions While better clarity is needed, efforts to coordinate prevention of both PTB and pre‐eclampsia, even though imperfect, are critically important as part of any program to make motherhood as safe as possible.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here